-
1
-
-
0007428697
-
-
Ferlay J, Soerjomataram I, Ervi M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. GLOBOCAN 2012 v1.0 Lyon, France
-
Ferlay J, Soerjomataram I, Ervi M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. GLOBOCAN 2012 v1.0 Lyon, France: International Agency for Research on Cancer, 2013. Available from: http://globocan.iarc.fr.
-
International Agency for Research on Cancer
-
-
-
2
-
-
35648996946
-
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies
-
PID: 17591622
-
Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut. 2007;56(11):1585–9.
-
(2007)
Gut
, vol.56
, Issue.11
, pp. 1585-1589
-
-
Brenner, H.1
Hoffmeister, M.2
Stegmaier, C.3
Brenner, G.4
Altenhofen, L.5
Haug, U.6
-
3
-
-
0031054991
-
Colorectal cancer screening: clinical guidelines and rationale
-
COI: 1:STN:280:DyaK2s7ns1OktA%3D%3D, PID: 9024315
-
Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594–642.
-
(1997)
Gastroenterology
, vol.112
, Issue.2
, pp. 594-642
-
-
Winawer, S.J.1
Fletcher, R.H.2
Miller, L.3
Godlee, F.4
Stolar, M.H.5
Mulrow, C.D.6
-
4
-
-
84898864070
-
-
Gupta S, Sussman DA, Doubeni CA, Anderson DS, Day L, Deshpande AR, et al
-
Gupta S, Sussman DA, Doubeni CA, Anderson DS, Day L, Deshpande AR, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. JNCI 2014;106(4):dju032.
-
Challenges and possible solutions to colorectal cancer screening for the underserved. JNCI
-
-
-
5
-
-
84861639726
-
Efficacy of a nationwide screening colonoscopy program for colorectal cancer
-
PID: 22446606, e2
-
Pox CP, Altenhofen L, Brenner H, Theilmeier A, Von Stillfried D, Schmiegel W. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology. 2012;142(7):1460–7. e2.
-
(2012)
Gastroenterology
, vol.142
, Issue.7
, pp. 1460-1467
-
-
Pox, C.P.1
Altenhofen, L.2
Brenner, H.3
Theilmeier, A.4
Von Stillfried, D.5
Schmiegel, W.6
-
6
-
-
84922568390
-
-
Luxembourg: Publications Office of the European Union
-
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition ed. Segnan N, Patnick J, von Karsa L, editors. Luxembourg: Publications Office of the European Union; 2010.
-
(2010)
editors
-
-
-
7
-
-
70350586935
-
Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy
-
COI: 1:STN:280:DC%2BD1MjitlGrsA%3D%3D, PID: 19866393
-
Panteris V, Haringsma J, Kuipers EJ. Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy. Endoscopy. 2009;41(11):941–51.
-
(2009)
Endoscopy
, vol.41
, Issue.11
, pp. 941-951
-
-
Panteris, V.1
Haringsma, J.2
Kuipers, E.J.3
-
8
-
-
84862556719
-
The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer
-
COI: 1:STN:280:DC%2BC38fosVaqsA%3D%3D, PID: 22723185
-
Kaminski MF, Bretthauer M, Zauber AG, Kuipers EJ, Adami HO, van Ballegooijen M, et al. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy. 2012;44(7):695–702.
-
(2012)
Endoscopy
, vol.44
, Issue.7
, pp. 695-702
-
-
Kaminski, M.F.1
Bretthauer, M.2
Zauber, A.G.3
Kuipers, E.J.4
Adami, H.O.5
van Ballegooijen, M.6
-
9
-
-
84871666335
-
Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials
-
PID: 23226108
-
Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9(12):e1001352.
-
(2012)
PLoS Med
, vol.9
, Issue.12
, pp. e1001352
-
-
Elmunzer, B.J.1
Hayward, R.A.2
Schoenfeld, P.S.3
Saini, S.D.4
Deshpande, A.5
Waljee, A.K.6
-
10
-
-
84862583882
-
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy
-
COI: 1:CAS:528:DC%2BC38XpvV2nu7s%3D, PID: 22612596
-
Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. NEJM. 2012;366(25):2345–57.
-
(2012)
NEJM
, vol.366
, Issue.25
, pp. 2345-2357
-
-
Schoen, R.E.1
Pinsky, P.F.2
Weissfeld, J.L.3
Yokochi, L.A.4
Church, T.5
Laiyemo, A.O.6
-
11
-
-
80052676840
-
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial–SCORE
-
PID: 21852264
-
Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial–SCORE. JNCI. 2011;103(17):1310–22.
-
(2011)
JNCI
, vol.103
, Issue.17
, pp. 1310-1322
-
-
Segnan, N.1
Armaroli, P.2
Bonelli, L.3
Risio, M.4
Sciallero, S.5
Zappa, M.6
-
12
-
-
77951879165
-
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
-
PID: 20430429
-
Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–33.
-
(2010)
Lancet
, vol.375
, Issue.9726
, pp. 1624-1633
-
-
Atkin, W.S.1
Edwards, R.2
Kralj-Hans, I.3
Wooldrage, K.4
Hart, A.R.5
Northover, J.M.6
-
13
-
-
84905901559
-
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial
-
COI: 1:CAS:528:DC%2BC2cXhs1equ7%2FE, PID: 25117129
-
Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312(6):606–15.
-
(2014)
JAMA
, vol.312
, Issue.6
, pp. 606-615
-
-
Holme, Ø.1
Løberg, M.2
Kalager, M.3
-
14
-
-
7444241437
-
The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps
-
PID: 15527807
-
Cappell MS. The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps. Med Clin North Am. 2005;89(1):1–42.
-
(2005)
Med Clin North Am
, vol.89
, Issue.1
, pp. 1-42
-
-
Cappell, M.S.1
-
16
-
-
84855329616
-
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial
-
PID: 22088831
-
Stoop EM, de Haan MC, de Wijkerslooth TR, Bossuyt PM, van Ballegooijen M, Nio CY, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 2012;13(1):55–64.
-
(2012)
Lancet Oncol
, vol.13
, Issue.1
, pp. 55-64
-
-
Stoop, E.M.1
de Haan, M.C.2
de Wijkerslooth, T.R.3
Bossuyt, P.M.4
van Ballegooijen, M.5
Nio, C.Y.6
-
17
-
-
0027223762
-
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study
-
COI: 1:STN:280:DyaK3s3jtlOhtQ%3D%3D, PID: 8474513
-
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. NEJM. 1993;328(19):1365–71.
-
(1993)
NEJM
, vol.328
, Issue.19
, pp. 1365-1371
-
-
Mandel, J.S.1
Bond, J.H.2
Church, T.R.3
Snover, D.C.4
Bradley, G.M.5
Schuman, L.M.6
-
18
-
-
0028329546
-
Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects
-
COI: 1:STN:280:DyaK2czhtVCjtg%3D%3D, PID: 8036464
-
Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol. 1994;29(5):468–73.
-
(1994)
Scand J Gastroenterol
, vol.29
, Issue.5
, pp. 468-473
-
-
Kewenter, J.1
Brevinge, H.2
Engaras, B.3
Haglind, E.4
Ahren, C.5
-
19
-
-
0030607603
-
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
-
COI: 1:STN:280:DyaK2s%2FpvVagtg%3D%3D, PID: 8942775
-
Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–7.
-
(1996)
Lancet
, vol.348
, Issue.9040
, pp. 1472-1477
-
-
Hardcastle, J.D.1
Chamberlain, J.O.2
Robinson, M.H.3
Moss, S.M.4
Amar, S.S.5
Balfour, T.W.6
-
20
-
-
0030607609
-
Randomised study of screening for colorectal cancer with faecal-occult-blood test
-
COI: 1:STN:280:DyaK2s%2FpvVagsQ%3D%3D, PID: 8942774
-
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467–71.
-
(1996)
Lancet
, vol.348
, Issue.9040
, pp. 1467-1471
-
-
Kronborg, O.1
Fenger, C.2
Olsen, J.3
Jorgensen, O.D.4
Sondergaard, O.5
-
21
-
-
44949242293
-
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update
-
PID: 18479499
-
Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.
-
(2008)
Am J Gastroenterol
, vol.103
, Issue.6
, pp. 1541-1549
-
-
Hewitson, P.1
Glasziou, P.2
Watson, E.3
Towler, B.4
Irwig, L.5
-
22
-
-
0015093654
-
Occult blood testing for detection of asymptomatic colon cancer
-
COI: 1:STN:280:DyaE38%2FhsF2gtg%3D%3D, PID: 5110619
-
Greegor DH. Occult blood testing for detection of asymptomatic colon cancer. Cancer. 1971;28(1):131–4.
-
(1971)
Cancer
, vol.28
, Issue.1
, pp. 131-134
-
-
Greegor, D.H.1
-
23
-
-
0014210397
-
Diagnosis of large-bowel cancer in the asymptomatic patient
-
COI: 1:STN:280:DyaF1c%2Fks1WntQ%3D%3D, PID: 6072632
-
Greegor DH. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA. 1967;201:943–5.
-
(1967)
JAMA
, vol.201
, pp. 943-945
-
-
Greegor, D.H.1
-
24
-
-
46049103362
-
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population
-
PID: 18482589
-
van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82–90.
-
(2008)
Gastroenterology
, vol.135
, Issue.1
, pp. 82-90
-
-
van Rossum, L.G.1
van Rijn, A.F.2
Laheij, R.J.3
van Oijen, M.G.4
Fockens, P.5
van Krieken, H.H.6
-
25
-
-
84874647348
-
Colorectal cancer screening—optimizing current strategies and new directions
-
COI: 1:CAS:528:DC%2BC3sXjsFGgs74%3D, PID: 23381005
-
Kuipers EJ, Rosch T, Bretthauer M. Colorectal cancer screening—optimizing current strategies and new directions. Nat Rev Clin Oncol. 2013;10(3):130–42.
-
(2013)
Nat Rev Clin Oncol
, vol.10
, Issue.3
, pp. 130-142
-
-
Kuipers, E.J.1
Rosch, T.2
Bretthauer, M.3
-
26
-
-
84896400466
-
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
-
COI: 1:CAS:528:DC%2BC3sXhtlaksr%2FJ, PID: 23852704, This paper provides a recommendation from an international expert panel that an immunochemical-based faecal occult blood test be used for screening asymptomatic subjects for colorectal cancer
-
Duffy MJ, Lamerz R, Haglund C, Nicolini A, Kalousová M, Holubec L, et al. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer. 2014;134(11):2513–22. This paper provides a recommendation from an international expert panel that an immunochemical-based faecal occult blood test be used for screening asymptomatic subjects for colorectal cancer.
-
(2014)
Int J Cancer
, vol.134
, Issue.11
, pp. 2513-2522
-
-
Duffy, M.J.1
Lamerz, R.2
Haglund, C.3
Nicolini, A.4
Kalousová, M.5
Holubec, L.6
-
27
-
-
84861578597
-
Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy?
-
PID: 22345655
-
Young GP, Fraser CG, Halloran SP, Cole S. Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy? Gut. 2012;61(7):959–60.
-
(2012)
Gut
, vol.61
, Issue.7
, pp. 959-960
-
-
Young, G.P.1
Fraser, C.G.2
Halloran, S.P.3
Cole, S.4
-
28
-
-
84896996529
-
Population screening for colorectal cancer means getting FIT. The past, present, and future of colorectal cancer screening using FIT
-
PID: 24672652
-
Allison JE, Fraser CG, Halloran SP, Young GP. Population screening for colorectal cancer means getting FIT. The past, present, and future of colorectal cancer screening using FIT. Gut and Liver. 2014;8:117–30.
-
(2014)
Gut and Liver
, vol.8
, pp. 117-130
-
-
Allison, J.E.1
Fraser, C.G.2
Halloran, S.P.3
Young, G.P.4
-
29
-
-
84858271005
-
Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening
-
PID: 22408764, The Cancer Care Ontario’s Fecal Immunochemical Tests (FIT) Guidelines Expert Panel reviewed the evidence for FIT and concluded that FIT performance is superior to guaiac-based faecal occult blood tests in terms of uptake of screening and the detection of colorectal cancer and advanced adenoma
-
Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol. 2012;26(3):131–47. The Cancer Care Ontario’s Fecal Immunochemical Tests (FIT) Guidelines Expert Panel reviewed the evidence for FIT and concluded that FIT performance is superior to guaiac-based faecal occult blood tests in terms of uptake of screening and the detection of colorectal cancer and advanced adenoma.
-
(2012)
Can J Gastroenterol
, vol.26
, Issue.3
, pp. 131-147
-
-
Rabeneck, L.1
Rumble, R.B.2
Thompson, F.3
Mills, M.4
Oleschuk, C.5
Whibley, A.6
-
30
-
-
0018871950
-
Immunochemical detection of fecal occult blood–the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer
-
COI: 1:STN:280:DyaL3c7jt1WmsQ%3D%3D, PID: 6965607
-
Songster CL, Barrows GH, Jarrett DD. Immunochemical detection of fecal occult blood–the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer. 1980;45(5 Suppl):1099–102.
-
(1980)
Cancer
, vol.45
, pp. 1099-1102
-
-
Songster, C.L.1
Barrows, G.H.2
Jarrett, D.D.3
-
31
-
-
63849113005
-
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels
-
COI: 1:STN:280:DC%2BD1M3kvFOhtQ%3D%3D, PID: 19337257
-
Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100(7):1103–10.
-
(2009)
Br J Cancer
, vol.100
, Issue.7
, pp. 1103-1110
-
-
Hol, L.1
Wilschut, J.A.2
van Ballegooijen, M.3
van Vuuren, A.J.4
van der Valk, H.5
Reijerink, J.C.6
-
32
-
-
84871621497
-
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication
-
von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51–9.
-
(2013)
Endoscopy
, vol.45
, Issue.1
, pp. 51-59
-
-
von Karsa, L.1
Patnick, J.2
Segnan, N.3
Atkin, W.4
Halloran, S.5
Lansdorp-Vogelaar, I.6
-
33
-
-
84866527934
-
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Faecal occult blood testing
-
PID: 23012123, A special edition of Endoscopy includes guidelines on faecal occult blood testing for colorectal cancer from the European Colorectal Cancer Screening Guidelines Working Group. The detailed description of guaiac-based tests and faecal immunochemical tests (FIT), and a review of the evidence for DNA and other related markers, highlights the superiority of quantitative FIT in terms of uptake, laboratory processes and disease detection and the opportunities FIT afford to adjust cut-offs for positivity to manage local colonoscopy resource
-
Halloran SP, Launoy G, Zappa M. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Faecal occult blood testing. Endoscopy. 2012;44(S 03):SE65–87. A special edition of Endoscopy includes guidelines on faecal occult blood testing for colorectal cancer from the European Colorectal Cancer Screening Guidelines Working Group. The detailed description of guaiac-based tests and faecal immunochemical tests (FIT), and a review of the evidence for DNA and other related markers, highlights the superiority of quantitative FIT in terms of uptake, laboratory processes and disease detection and the opportunities FIT afford to adjust cut-offs for positivity to manage local colonoscopy resource.
-
(2012)
Endoscopy
, vol.44
, Issue.S 03
, pp. SE65-SE87
-
-
Halloran, S.P.1
Launoy, G.2
Zappa, M.3
-
34
-
-
85006184296
-
Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity
-
Steele RJC, McDonald PJ, Digby J, Brownlee LA, Strachan JA, Libby G, et al. Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. U Eur Gastroenterol J. 2013;1(3):198–205.
-
(2013)
U Eur Gastroenterol J
, vol.1
, Issue.3
, pp. 198-205
-
-
Steele, R.J.C.1
McDonald, P.J.2
Digby, J.3
Brownlee, L.A.4
Strachan, J.A.5
Libby, G.6
-
35
-
-
84873410891
-
Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening
-
PID: 22387523
-
van Roon AHC, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CWN, Biermann K, et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut. 2013;62(3):409–15.
-
(2013)
Gut
, vol.62
, Issue.3
, pp. 409-415
-
-
van Roon, A.H.C.1
Goede, S.L.2
van Ballegooijen, M.3
van Vuuren, A.J.4
Looman, C.W.N.5
Biermann, K.6
-
36
-
-
84886055182
-
Screening for colorectal cancer in Italy, 2010 survey
-
PID: 23293271, Lo screening colorettale in Italia, survey 2010
-
Zorzi M, Fedato C, Grazzini G, Sassoli de’ Bianchi P, Naldoni C, Pendenza M, et al. Screening for colorectal cancer in Italy, 2010 survey. Epidemiol Prev. 2012;36(6 Suppl 1):55–77. Lo screening colorettale in Italia, survey 2010.
-
(2012)
Epidemiol Prev
, vol.36
, pp. 55-77
-
-
Zorzi, M.1
Fedato, C.2
Grazzini, G.3
Sassoli de’ Bianchi, P.4
Naldoni, C.5
Pendenza, M.6
-
37
-
-
84922505911
-
-
Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 2014. Epub 2014/09/01
-
Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 2014. Epub 2014/09/01. This recent paper reports a significant reduction in CRC mortality in FIT-based screening programmes in Italy.
-
This recent paper reports a significant reduction in CRC mortality in FIT-based screening programmes in Italy
-
-
-
38
-
-
79952835583
-
Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance
-
PID: 21185397
-
van Roon AH, Wilschut JA, Hol L, van Ballegooijen M, Reijerink JC, t Mannetje H, et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol. 2011;9(4):333–9.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, Issue.4
, pp. 333-339
-
-
van Roon, A.H.1
Wilschut, J.A.2
Hol, L.3
van Ballegooijen, M.4
Reijerink, J.C.5
t Mannetje, H.6
-
39
-
-
80053595590
-
Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study
-
Oort FA, van Turenhout ST, Coupe VM, van der Hulst RW, Wesdorp EI, Terhaar sive Droste JS, et al. Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study. BMC Cancer. 2011;11:434.
-
(2011)
BMC Cancer
, vol.11
, pp. 434
-
-
Oort, F.A.1
van Turenhout, S.T.2
Coupe, V.M.3
van der Hulst, R.W.4
Wesdorp, E.I.5
Terhaar sive Droste, J.S.6
-
40
-
-
0029944883
-
Influence of delay in stool sampling on fecal occult blood test sensitivity
-
COI: 1:CAS:528:DyaK28XktFWmsb8%3D, PID: 8674197
-
Young GP, Sinatra MA, St John DJ. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clin Chem. 1996;42(7):1107–8.
-
(1996)
Clin Chem
, vol.42
, Issue.7
, pp. 1107-1108
-
-
Young, G.P.1
Sinatra, M.A.2
St John, D.J.3
-
41
-
-
0142075833
-
Moisture content of hemoccult slides influences test sensitivity
-
PID: 14501620
-
Faure H, Exbrayat C, Winckel P, Bolla M. Moisture content of hemoccult slides influences test sensitivity. Eur J Gastroenterol Hepatol. 2003;15(10):1111–4.
-
(2003)
Eur J Gastroenterol Hepatol
, vol.15
, Issue.10
, pp. 1111-1114
-
-
Faure, H.1
Exbrayat, C.2
Winckel, P.3
Bolla, M.4
-
42
-
-
84865410909
-
Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening
-
COI: 1:STN:280:DC%2BC38zotFSjtA%3D%3D, PID: 22122559
-
Hunter JP, Saratzis A, Froggatt P, Harmston C. Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening. Colorectal Dis. 2012;14(9):1084–9.
-
(2012)
Colorectal Dis
, vol.14
, Issue.9
, pp. 1084-1089
-
-
Hunter, J.P.1
Saratzis, A.2
Froggatt, P.3
Harmston, C.4
-
43
-
-
85016912452
-
PWE-020: do seasonal trends in positivity exist with the guaiac-based faecal occult blood test?
-
Seaman HE, Butler P, Snowball JM, Halloran SP. PWE-020: do seasonal trends in positivity exist with the guaiac-based faecal occult blood test? Gut. 2013;62 Suppl 1:A137–8.
-
(2013)
Gut
, vol.62
, pp. A137-A138
-
-
Seaman, H.E.1
Butler, P.2
Snowball, J.M.3
Halloran, S.P.4
-
44
-
-
78149246577
-
Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district
-
PID: 20603498
-
Grazzini G, Ventura L, Zappa M, Ciatto S, Confortini M, Rapi S, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut. 2010;59(11):1511–5.
-
(2010)
Gut
, vol.59
, Issue.11
, pp. 1511-1515
-
-
Grazzini, G.1
Ventura, L.2
Zappa, M.3
Ciatto, S.4
Confortini, M.5
Rapi, S.6
-
45
-
-
79960105485
-
Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening
-
PID: 21576271
-
Guittet L, Guillaume E, Levillain R, Beley P, Tichet J, Lantieri O, et al. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1492–501.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, Issue.7
, pp. 1492-1501
-
-
Guittet, L.1
Guillaume, E.2
Levillain, R.3
Beley, P.4
Tichet, J.5
Lantieri, O.6
-
46
-
-
84855471295
-
Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial
-
PID: 22108450
-
van Roon AHC, Hol L, van Vuuren AJ, Francke J, Ouwendijk M, Heijens A, et al. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol. 2012;107(1):99–107.
-
(2012)
Am J Gastroenterol
, vol.107
, Issue.1
, pp. 99-107
-
-
van Roon, A.H.C.1
Hol, L.2
van Vuuren, A.J.3
Francke, J.4
Ouwendijk, M.5
Heijens, A.6
-
47
-
-
84922623443
-
-
Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening, Int J Cancer:
-
Chausserie S, Levillain R, Puvinel J, Ferrand O, Ruiz A, Raginel T, et al. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening. Int J Cancer 2014.
-
(2014)
et al
-
-
Chausserie, S.1
Levillain, R.2
Puvinel, J.3
Ferrand, O.4
Ruiz, A.5
Raginel, T.6
-
48
-
-
84857798015
-
Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site
-
COI: 1:STN:280:DC%2BC383nsVynsQ%3D%3D, PID: 21930729
-
Steele RJC, McClements P, Watling C, Libby G, Weller D, Brewster DH, et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut. 2012;61(4):576–81.
-
(2012)
Gut
, vol.61
, Issue.4
, pp. 576-581
-
-
Steele, R.J.C.1
McClements, P.2
Watling, C.3
Libby, G.4
Weller, D.5
Brewster, D.H.6
-
49
-
-
79958217696
-
High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region
-
Zorzi M, Fedato C, Grazzini G, Stocco FC, Banovich F, Bortoli A, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region. Italy Gut. 2011;60(7):944–9.
-
(2011)
Italy Gut
, vol.60
, Issue.7
, pp. 944-949
-
-
Zorzi, M.1
Fedato, C.2
Grazzini, G.3
Stocco, F.C.4
Banovich, F.5
Bortoli, A.6
-
50
-
-
0037258228
-
Gender differences in gut transit shown with a newly developed radiological procedure
-
COI: 1:STN:280:DC%2BD3s%2FpsF2qtA%3D%3D, PID: 12608462
-
Sadik R, Abrahamsson H, Stotzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol. 2003;38(1):36–42.
-
(2003)
Scand J Gastroenterol
, vol.38
, Issue.1
, pp. 36-42
-
-
Sadik, R.1
Abrahamsson, H.2
Stotzer, P.O.3
-
51
-
-
84876761362
-
Faecal haemoglobin concentration is related to severity of colorectal neoplasia
-
COI: 1:CAS:528:DC%2BC3sXpt1Cit7o%3D, PID: 23418340
-
Digby J, Fraser CG, Carey FA, McDonald PJ, Strachan JA, Diament RH, et al. Faecal haemoglobin concentration is related to severity of colorectal neoplasia. J Clin Pathol. 2013;66(5):415–9.
-
(2013)
J Clin Pathol
, vol.66
, Issue.5
, pp. 415-419
-
-
Digby, J.1
Fraser, C.G.2
Carey, F.A.3
McDonald, P.J.4
Strachan, J.A.5
Diament, R.H.6
-
52
-
-
84893430714
-
Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy
-
PID: 23964098, This Dutch group developed a risk prediction model for use in CRC screening, incorporating the FIT result with other known risk factors for CRC and demonstrated that combining risk stratification with the FIT result increased the accuracy of FIT screening
-
Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut. 2014;63(3):466–71. This Dutch group developed a risk prediction model for use in CRC screening, incorporating the FIT result with other known risk factors for CRC and demonstrated that combining risk stratification with the FIT result increased the accuracy of FIT screening.
-
(2014)
Gut
, vol.63
, Issue.3
, pp. 466-471
-
-
Stegeman, I.1
de Wijkerslooth, T.R.2
Stoop, E.M.3
van Leerdam, M.E.4
Dekker, E.5
van Ballegooijen, M.6
-
53
-
-
0027513868
-
Detection of colorectal cancer by faecal α1-Antitrypsin
-
PID: 8434864
-
Moran A, Radley S, Neoptolemos J, Jones AF, Asquith P. Detection of colorectal cancer by faecal α1-Antitrypsin. Ann Clin Biochem. 1993;30(1):28–33.
-
(1993)
Ann Clin Biochem
, vol.30
, Issue.1
, pp. 28-33
-
-
Moran, A.1
Radley, S.2
Neoptolemos, J.3
Jones, A.F.4
Asquith, P.5
-
54
-
-
0023278087
-
ELISA for occult faecal albumin
-
Nakayama T, Yasuoka H, Kishino T, Ohguchi H, Takada M. ELISA for occult faecal albumin. Lancet. 1987;329(8546):1368–9.
-
(1987)
Lancet
, vol.329
, Issue.8546
, pp. 1368-1369
-
-
Nakayama, T.1
Yasuoka, H.2
Kishino, T.3
Ohguchi, H.4
Takada, M.5
-
55
-
-
0026571843
-
Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests
-
COI: 1:STN:280:DyaK38%2FpsFaqsg%3D%3D, PID: 1728128
-
Miyoshi H, Ohshiba S, Asada S, Hirata I, Uchida K. Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests. Am J Gastroenterol. 1992;87(1):67–73.
-
(1992)
Am J Gastroenterol
, vol.87
, Issue.1
, pp. 67-73
-
-
Miyoshi, H.1
Ohshiba, S.2
Asada, S.3
Hirata, I.4
Uchida, K.5
-
56
-
-
0026524601
-
Fecal lysozyme: an unreliable marker for colorectal cancer
-
COI: 1:CAS:528:DyaK38XmtV2ru74%3D, PID: 1595650
-
Dubrow R, Kim CS, Eldred AK. Fecal lysozyme: an unreliable marker for colorectal cancer. Am J Gastroenterol. 1992;87(5):617–21.
-
(1992)
Am J Gastroenterol
, vol.87
, Issue.5
, pp. 617-621
-
-
Dubrow, R.1
Kim, C.S.2
Eldred, A.K.3
-
57
-
-
84871479837
-
Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis
-
COI: 1:CAS:528:DC%2BC38Xht1eru7%2FE, PID: 22912551
-
Tonus C, Sellinger M, Koss K, Neupert G. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis. World J Gastroenterol. 2012;18(30):4004–11.
-
(2012)
World J Gastroenterol
, vol.18
, Issue.30
, pp. 4004-4011
-
-
Tonus, C.1
Sellinger, M.2
Koss, K.3
Neupert, G.4
-
58
-
-
10844281210
-
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population
-
COI: 1:CAS:528:DC%2BD2MXhtFWisQ%3D%3D, PID: 15616205
-
Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. NEJM. 2004;351(26):2704–14.
-
(2004)
NEJM
, vol.351
, Issue.26
, pp. 2704-2714
-
-
Imperiale, T.F.1
Ransohoff, D.F.2
Itzkowitz, S.H.3
Turnbull, B.A.4
Ross, M.E.5
-
59
-
-
53749091845
-
Stool DNA and occult blood testing for screen detection of colorectal neoplasia
-
PID: 18838724, –50, W81
-
Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008;149(7):441. –50, W81.
-
(2008)
Ann Intern Med
, vol.149
, Issue.7
, pp. 441
-
-
Ahlquist, D.A.1
Sargent, D.J.2
Loprinzi, C.L.3
Levin, T.R.4
Rex, D.K.5
Ahnen, D.J.6
-
60
-
-
84897509377
-
Multitarget stool DNA testing for colorectal-cancer screening
-
COI: 1:CAS:528:DC%2BC2cXlvFGltrw%3D, PID: 24645800, Imperiale et al. compared the performance of a multi-target stool DNA test plus FIT with FIT alone for the detection of CRC and adenomas in average-risk subjects. The multi-target test demonstrated superior sensitivity but was less specific than FIT alone; the practicalities and expense of the multi-target stool test currently preclude consideration for use in routine population-based CRC screening programmes
-
Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. NEJM. 2014;370:1287–97. Imperiale et al. compared the performance of a multi-target stool DNA test plus FIT with FIT alone for the detection of CRC and adenomas in average-risk subjects. The multi-target test demonstrated superior sensitivity but was less specific than FIT alone; the practicalities and expense of the multi-target stool test currently preclude consideration for use in routine population-based CRC screening programmes.
-
(2014)
NEJM
, vol.370
, pp. 1287-1297
-
-
Imperiale, T.F.1
Ransohoff, D.F.2
Itzkowitz, S.H.3
Levin, T.R.4
Lavin, P.5
Lidgard, G.P.6
-
61
-
-
84903908476
-
Multitarget stool DNA testing for colorectal-cancer screening
-
PID: 25006738
-
Senore C, Segnan N. Multitarget stool DNA testing for colorectal-cancer screening. NEJM. 2014;371(2):185–6.
-
(2014)
NEJM
, vol.371
, Issue.2
, pp. 185-186
-
-
Senore, C.1
Segnan, N.2
-
63
-
-
0037096946
-
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas
-
COI: 1:CAS:528:DC%2BD38XkslWqsLY%3D, PID: 12067979
-
Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, et al. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res. 2002;62(12):3382–6.
-
(2002)
Cancer Res
, vol.62
, Issue.12
, pp. 3382-3386
-
-
Toyooka, S.1
Toyooka, K.O.2
Harada, K.3
Miyajima, K.4
Makarla, P.5
Sathyanarayana, U.G.6
-
64
-
-
0033894117
-
Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors
-
COI: 1:CAS:528:DC%2BD3cXlvFOksbY%3D, PID: 10945606
-
Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res. 2000;60(15):4044–8.
-
(2000)
Cancer Res
, vol.60
, Issue.15
, pp. 4044-4048
-
-
Toyota, M.1
Shen, L.2
Ohe-Toyota, M.3
Hamilton, S.R.4
Sinicrope, F.A.5
Issa, J.P.6
-
65
-
-
33644686386
-
Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers
-
COI: 1:CAS:528:DC%2BD2MXht1Sitr7M
-
Ebert MP, Mooney SH, Tonnes-Priddy L, Lograsso J, Hoffmann J, Chen J, et al. Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers. Neoplasia (New York, NY). 2005;7(8):771–8.
-
(2005)
Neoplasia (New York, NY)
, vol.7
, Issue.8
, pp. 771-778
-
-
Ebert, M.P.1
Mooney, S.H.2
Tonnes-Priddy, L.3
Lograsso, J.4
Hoffmann, J.5
Chen, J.6
-
66
-
-
39749180354
-
DNA methylation biomarkers for blood-based colorectal cancer screening
-
COI: 1:CAS:528:DC%2BD1cXhs1Clsr0%3D, PID: 18089654
-
Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008;54(2):414–23.
-
(2008)
Clin Chem
, vol.54
, Issue.2
, pp. 414-423
-
-
Lofton-Day, C.1
Model, F.2
Devos, T.3
Tetzner, R.4
Distler, J.5
Schuster, M.6
-
67
-
-
67650077151
-
Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer
-
de Vos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55(7):1337–46.
-
(2009)
Clin Chem
, vol.55
, Issue.7
, pp. 1337-1346
-
-
de Vos, T.1
Tetzner, R.2
Model, F.3
Weiss, G.4
Schuster, M.5
Distler, J.6
-
68
-
-
84891743167
-
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
-
COI: 1:CAS:528:DC%2BC2cXkslart74%3D, PID: 23408352
-
Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014;63(2):317–25.
-
(2014)
Gut
, vol.63
, Issue.2
, pp. 317-325
-
-
Church, T.R.1
Wandell, M.2
Lofton-Day, C.3
Mongin, S.J.4
Burger, M.5
Payne, S.R.6
-
69
-
-
77954911155
-
Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme
-
COI: 1:STN:280:DC%2BC3cjgt1Kmsw%3D%3D, PID: 20660434
-
Steele RJC, Kostourou I, McClements P, Watling C, Libby G, Weller D, et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen. 2010;17(2):68–74.
-
(2010)
J Med Screen
, vol.17
, Issue.2
, pp. 68-74
-
-
Steele, R.J.C.1
Kostourou, I.2
McClements, P.3
Watling, C.4
Libby, G.5
Weller, D.6
-
70
-
-
83555179239
-
Performance measures in three rounds of the English bowel cancer screening pilot
-
COI: 1:STN:280:DC%2BC38%2FksVSkuw%3D%3D, PID: 21561880
-
Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut. 2012;61(1):101–7.
-
(2012)
Gut
, vol.61
, Issue.1
, pp. 101-107
-
-
Moss, S.M.1
Campbell, C.2
Melia, J.3
Coleman, D.4
Smith, S.5
Parker, R.6
-
71
-
-
79957602740
-
Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England
-
von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40(3):712–8.
-
(2011)
Int J Epidemiol
, vol.40
, Issue.3
, pp. 712-718
-
-
von Wagner, C.1
Baio, G.2
Raine, R.3
Snowball, J.4
Morris, S.5
Atkin, W.6
-
72
-
-
84857422764
-
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening
-
COI: 1:CAS:528:DC%2BC38XjtFOqtrw%3D, PID: 22356323
-
Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. NEJM. 2012;366(8):697–706.
-
(2012)
NEJM
, vol.366
, Issue.8
, pp. 697-706
-
-
Quintero, E.1
Castells, A.2
Bujanda, L.3
Cubiella, J.4
Salas, D.5
Lanas, Á.6
-
73
-
-
73449097516
-
Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy
-
COI: 1:STN:280:DC%2BD1Mfhs1akuw%3D%3D, PID: 19671542
-
Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(1):62–8.
-
(2010)
Gut
, vol.59
, Issue.1
, pp. 62-68
-
-
Hol, L.1
van Leerdam, M.E.2
van Ballegooijen, M.3
van Vuuren, A.J.4
van Dekken, H.5
Reijerink, J.C.6
-
74
-
-
20644468405
-
The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial
-
PID: 15949119
-
Federici A, Giorgi Rossi P, Borgia P, Bartolozzi F, Farchi S, Gausticchi G. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen. 2005;12(2):83–8.
-
(2005)
J Med Screen
, vol.12
, Issue.2
, pp. 83-88
-
-
Federici, A.1
Giorgi Rossi, P.2
Borgia, P.3
Bartolozzi, F.4
Farchi, S.5
Gausticchi, G.6
-
75
-
-
77952583613
-
Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial
-
PID: 20307568
-
Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med. 2010;50(5–6):297–9.
-
(2010)
Prev Med
, vol.50
, Issue.5-6
, pp. 297-299
-
-
Hoffman, R.M.1
Steel, S.2
Yee, E.F.3
Massie, L.4
Schrader, R.M.5
Murata, G.H.6
-
76
-
-
84863783481
-
Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis
-
PID: 22634386, This systematic review of the published literature comparing participation in colorectal cancer screening programmes using a FIT with programmes using a guaiac-based faecal occult blood test reported significantly higher participation with FIT
-
Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev Med. 2012;55(2):87–92. This systematic review of the published literature comparing participation in colorectal cancer screening programmes using a FIT with programmes using a guaiac-based faecal occult blood test reported significantly higher participation with FIT.
-
(2012)
Prev Med
, vol.55
, Issue.2
, pp. 87-92
-
-
Vart, G.1
Banzi, R.2
Minozzi, S.3
-
77
-
-
84875844899
-
Offering people a choice for colorectal cancer screening
-
PID: 22442162
-
Senore C, Ederle A, Benazzato L, Arrigoni A, Silvani M, Fantin A, et al. Offering people a choice for colorectal cancer screening. Gut. 2013;62(5):735–40.
-
(2013)
Gut
, vol.62
, Issue.5
, pp. 735-740
-
-
Senore, C.1
Ederle, A.2
Benazzato, L.3
Arrigoni, A.4
Silvani, M.5
Fantin, A.6
-
78
-
-
84865404456
-
Re-appraisal of the options for colorectal cancer screening in England
-
Whyte S, Chilcott J, Halloran S. Re-appraisal of the options for colorectal cancer screening in England. Colorectal Dis 2012.
-
(2012)
Colorectal Dis
-
-
Whyte, S.1
Chilcott, J.2
Halloran, S.3
|